Duplicate_Azienda Ospedaliera Univ. Meyer /ID# 168049

Florence, Tuscany 50139

0 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment — Completed